Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography

Acta Medica Austriaca

Volumn 26, Issue 3, 1999, Pages 105-108

  Lipp, R W ^a   Schnedl, W J ^a   Aglas, F ^a   Ranner, G ^a   Beham Schmid, Christine ^a   Leb, G ^a   Sill, H ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bone marrow involvement; Extended SPET; Non Hodgkin's lymphoma; Somatostatin receptor specific scintigraphy

Indexed keywords

GRANULOCYTE ANTIBODY; MONOCLONAL ANTIBODY 250 183; PENTETREOTIDE; PENTETREOTIDE IN 111; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; CANCER LOCALIZATION; CANCER SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NONHODGKIN LYMPHOMA; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BONE MARROW; GAMMA CAMERAS; HUMANS; INDIUM RADIOISOTOPES; LYMPHOMA, NON-HODGKIN; NEOPLASM STAGING; OCTREOTIDE; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032844413     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bares R, Galonska P, Dempke W, Handt S, Büll U, Osieka R. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by Positron-Emission-Tomography. Hormon Metab Res Suppl 1993;27:56-58.
2. Bong SB, VanderLaan JG, Louwes H, Schuurman JJ. Clinical experience with somatostatin receptor imaging in lymphoma. Semin Oncol 1994;21 (suppl. 13) 46-50.
3. Cerulus G, Leonard JP. A comparison of 111In-octreotide and 67Ga scintigraphy in malignant lymphoma. Nucl Med Commun 1997;18:616-622.
4. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
5. Leners N, Jamar F, Fiasse R, Ferrani A, Pauwels S. Indium-111-pentetreotide uptake in endocrine tumors and lymphoma. J Nucl Med 1996;37:916-922.
6. Lipp RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs GJ. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy. J Nucl Med 1995;36:13-18.
7. Reubi JC, Waser B, Van Hagen M, Lamberts SWJ, Krenning EP, Gebbers JO, Laissue JA. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer 1992;50:895-900.
8. Stansfield AG, Diebold J, Noel H. Updated Kiel classification for lymphomas. Lancet 1988;603:292-293.
9. Van den Anker-Lutgenburg PJ, Lowenberg B, Lamberts SWJ, Krenning EP. The Relevance of somatostatin receptor expression in malignant lymphomas. Metabolism 1996;45 (suppl 1):96-97.
10. van den Anker Lutgenburg PJ, Löwenberg B, Lamberts SWJ, Oei HY, Valkema R, Krenning EP. Somatostatin receptor scintigraphy in the staging of non-Hodgkin Lymphomas (abstract). J Nucl Med 1996;37:19P.
11. Van Hagen PM, Krenning EP, Reubi JC, Mulder AH, Bakker WH, Oei HY, Löwenberg B, Lamberts SWJ. Somatostatin analogue scintigraphy of malignant lymphomas. Br J Haematology 1993;83:75-79.